No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Cantor Fitzgerald Initiates Coverage on Protara Therapeutics With Overweight Rating
LifeSci Capital Maintains Protara Therapeutics(TARA.US) With Buy Rating, Announces Target Price $22
Protara Therapeutics Price Target Announced at $22.00/Share by LifeSci Capital
Protara Therapeutics Initiated at Outperform by LifeSci Capital
TD Cowen Maintains Protara Therapeutics(TARA.US) With Buy Rating, Announces Target Price $30
H.C. Wainwright Maintains Protara Therapeutics(TARA.US) With Buy Rating, Maintains Target Price $23